Inventor · disambiguated record
C. Simone Jude-Fishburn
Also filed as: JUDE-FISHBURN C SIMONE
7 granted patents·7 pending applications·27 citations·filing 2009–2021
81Inventor score
Top patents by PatentIndex Score
14 records- 0190US9155797B2Oligomer-cannabinoid conjugatesNEKTAR THERAPEUTICS·Filed 2014·Granted Oct 13, 2015·13 cites·11 claims
- 0287US8829043B2Oligome-cannabinoid conjugatesRIGGS-SAUTHIER JENNIFER·Filed 2009·Granted Sep 9, 2014·10 cites·13 claims
- 0385US11129794B2Chemically modified small moleculesNEKTAR THERAPEUTICS·Filed 2018·Granted Sep 28, 2021·1 cites·14 claims
- 0485US9682153B2Polymer conjugates of therapeutic peptidesNEKTAR THERAPEUTICS·Filed 2015·Granted Jun 20, 2017·3 cites·12 claims
- 0573US2011195940A1Protease Inhibitors Having Enhanced FeaturesNEKTAR THERAPEUTICS·Filed 2009·Application pending·0 cites
- 0667US10806794B2Protease inhibitors having enhanced featuresNEKTAR THERAPEUTICS·Filed 2018·Granted Oct 20, 2020·0 cites·7 claims
- 0765US11033631B2Methods of treating CYP2D6 alternative metabolizersELDON MICHAEL A·Filed 2009·Granted Jun 15, 2021·0 cites·9 claims
- 0861US10092656B2Protease inhibitors having enhanced featuresNEKTAR THERAPEUTICS·Filed 2016·Granted Oct 9, 2018·0 cites·7 claims
- 0959US2011237614A1Pegylated Opioids with Low Potential for AbuseNEKTAR THERAPEUTICS·Filed 2009·Application pending·0 cites
- 1057US2021401998A1Methods of treating cyp2d6 alternative metabolizersNEKTAR THERAPEUTICS·Filed 2021·Application pending·0 cites
- 1153US2019070251A1Polymer conjugates of therapeutic peptidesNEKTAR THERAPEUTICS·Filed 2017·Application pending·0 cites
- 1250US2011171163A1Polymer conjugates of ziconotide peptidesNEKTAR THERAPEUTICS·Filed 2009·Application pending·0 cites
- 1343US2013023553A1Pegylated opioids with low potential for abuse and side effectsNEKTAR THERAPEUTICS·Filed 2011·Application pending·0 cites
- 1442US2016243111A1Pegylated Opioids with Low Potential for AbuseNEKTAR THERAPEUTICS·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →